Category: RESEARCH

Featured

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Editor | Curator - June 24, 2025

2024 WATCH LIST

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

Editor | Curator - April 3, 2024

ALCOHOL

1000 Days Without Alcohol: Here’s What Happened

Editor | Curator - February 7, 2024

Psychedelic Stock Review Initiates Coverage on Ehave Inc.

PSYCH STOCK NEWS Editor | Curator - October 2, 2021

Psychedelic Stock Review Initiates Coverage on Ehave Inc. MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics...

View Post

Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company

RESEARCH Editor | Curator - September 24, 2021

WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE What exactly is a favorite? First what it isn’t. In early August our research team...

View Post

Subscribe for Free!

RESEARCH Editor | Curator - August 9, 2021

EXCELLENT CHOICE, SIR! AND CHEERS TO YOU FOR SUBSCRIBING Subscribe For Your Free Copy to the 2024 Psychedelic Investor Guide

View Post

Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.

RESEARCH Editor | Curator - July 27, 2021

Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target. REPORT

View Post